Hudson Valley Investment Advisors Inc Amgen Inc Transaction History

Hudson Valley Investment Advisors Inc

$912 Million
Q2 2025

A detailed history of Hudson Valley Investment Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, Hudson Valley Investment Advisors Inc holds 1,268 shares of AMGN stock, worth $388,743. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,268

Previous 1,250 1.44%

Holding current value

$388,743

Previous $389,000 9.0%

% of portfolio

0.04%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	BUY	$262.28 - $309.85 $4,721 - $5,577	18 Added 1.44%	1,268 $354,000
Q3 2024 Oct 25, 2024	SELL	$309.38 - $337.38 $157,783 - $172,063	-510 Reduced 28.98%	1,250 $402,000
Q2 2024 Jul 02, 2024	BUY	$262.75 - $319.31 $134,002 - $162,848	510 Added 40.8%	1,760 $549,000
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $137,123 - $165,525	-510 Reduced 28.98%	1,250 $355,000
Q4 2023 Jan 12, 2024	BUY	$255.7 - $288.46 $15,342 - $17,307	60 Added 3.53%	1,760 $506,000
Q3 2023 Oct 27, 2023	SELL	$218.65 - $271.46 $114,572 - $142,245	-524 Reduced 23.56%	1,700 $456,000
Q2 2023 Jul 17, 2023	BUY	$214.27 - $253.37 $2,142 - $2,533	10 Added 0.45%	2,224 $493,000
Q3 2022 Oct 11, 2022	SELL	$224.46 - $253.15 $31,648 - $35,694	-141 Reduced 5.99%	2,214 $499,000
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $23,071 - $25,674	-100 Reduced 4.07%	2,355 $573,000
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $6,578 - $7,277	-30 Reduced 1.21%	2,455 $594,000
Q4 2021 Jan 24, 2022	SELL	$198.88 - $227.6 $19,888 - $22,760	-100 Reduced 3.87%	2,485 $559,000
Q2 2021 Jul 07, 2021	SELL	$233.58 - $259.14 $78,249 - $86,811	-335 Reduced 11.47%	2,585 $630,000
Q1 2021 Apr 23, 2021	SELL	$221.91 - $258.6 $27,738 - $32,325	-125 Reduced 4.11%	2,920 $727,000
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $52,326 - $58,191	-223 Reduced 6.82%	3,045 $774,000
Q2 2020 Jul 07, 2020	SELL	$197.81 - $242.74 $72,991 - $89,571	-369 Reduced 10.15%	3,268 $771,000
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $183,880 - $243,875	-1,009 Reduced 21.72%	3,637 $737,000
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $9,460 - $12,160	50 Added 1.09%	4,646 $1.12 Million
Q3 2019 Oct 18, 2019	SELL	$174.11 - $208.62 $43,353 - $51,946	-249 Reduced 5.14%	4,596 $889,000
Q2 2019 Jul 16, 2019	SELL	$166.7 - $195.41 $1.03 Million - $1.2 Million	-6,159 Reduced 55.97%	4,845 $893,000
Q1 2019 Apr 10, 2019	SELL	$180.87 - $203.88 $734,693 - $828,160	-4,062 Reduced 26.96%	11,004 $2.09 Million
Q4 2018 Jan 17, 2019	BUY	$178.4 - $208.25 $565,349 - $659,944	3,169 Added 26.64%	15,066 $2.93 Million
Q3 2018 Oct 12, 2018	SELL	$185.29 - $208.89 $49,843 - $56,191	-269 Reduced 2.21%	11,897 $2.47 Million
Q2 2018 Jul 10, 2018	BUY	$166.05 - $186.51 $73,892 - $82,996	445 Added 3.8%	12,166 $2.25 Million
Q1 2018 Apr 12, 2018	BUY	$169.43 - $198.0 $117,414 - $137,214	693 Added 6.28%	11,721 $2 Million
Q4 2017 Jan 16, 2018	BUY	$168.79 - $188.59 $9,452 - $10,561	56 Added 0.51%	11,028 $1.92 Million
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $1.84 Million - $2.1 Million	10,972	10,972 $2.05 Million

Others Institutions Holding AMGN

# of Institutions

3,285

Shares Held

426M

Call Options Held

8.07M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Valley Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hudson Valley Investment Advisors Inc with notifications on news.

Account

Hudson Valley Investment Advisors Inc Amgen Inc Transaction History